American Century Companies Inc. Acquires 45,322 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

American Century Companies Inc. increased its holdings in Inspire Medical Systems, Inc. (NYSE:INSPFree Report) by 921.4% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 50,241 shares of the company’s stock after purchasing an additional 45,322 shares during the period. American Century Companies Inc.’s holdings in Inspire Medical Systems were worth $9,970,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Commonwealth Equity Services LLC boosted its holdings in Inspire Medical Systems by 0.5% in the 1st quarter. Commonwealth Equity Services LLC now owns 6,774 shares of the company’s stock valued at $1,585,000 after purchasing an additional 36 shares during the period. Metropolitan Life Insurance Co NY lifted its holdings in shares of Inspire Medical Systems by 2.3% during the 4th quarter. Metropolitan Life Insurance Co NY now owns 1,734 shares of the company’s stock worth $437,000 after acquiring an additional 39 shares during the last quarter. Mercer Global Advisors Inc. ADV lifted its holdings in shares of Inspire Medical Systems by 3.9% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 1,122 shares of the company’s stock worth $364,000 after acquiring an additional 42 shares during the last quarter. Y Intercept Hong Kong Ltd lifted its holdings in shares of Inspire Medical Systems by 3.7% during the 2nd quarter. Y Intercept Hong Kong Ltd now owns 1,200 shares of the company’s stock worth $390,000 after acquiring an additional 43 shares during the last quarter. Finally, Pathstone Family Office LLC lifted its holdings in shares of Inspire Medical Systems by 2.7% during the 3rd quarter. Pathstone Family Office LLC now owns 2,273 shares of the company’s stock worth $403,000 after acquiring an additional 59 shares during the last quarter. 94.91% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Mizuho lifted their target price on shares of Inspire Medical Systems from $225.00 to $250.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. Stifel Nicolaus reiterated a “hold” rating and issued a $210.00 target price on shares of Inspire Medical Systems in a research report on Tuesday, January 2nd. Wells Fargo & Company cut shares of Inspire Medical Systems from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $245.00 to $187.00 in a research report on Wednesday, December 13th. Jefferies Financial Group assumed coverage on shares of Inspire Medical Systems in a research report on Friday, January 19th. They issued a “buy” rating and a $245.00 target price on the stock. Finally, Morgan Stanley assumed coverage on shares of Inspire Medical Systems in a research report on Tuesday, March 19th. They issued an “overweight” rating and a $250.00 target price on the stock. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $271.29.

Get Our Latest Stock Report on INSP

Insider Activity at Inspire Medical Systems

In related news, insider Randy Ban sold 12,230 shares of the firm’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $185.37, for a total transaction of $2,267,075.10. Following the completion of the transaction, the insider now owns 3,029 shares of the company’s stock, valued at approximately $561,485.73. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Inspire Medical Systems news, Director Jerry C. Griffin sold 554 shares of Inspire Medical Systems stock in a transaction on Monday, March 18th. The stock was sold at an average price of $193.53, for a total value of $107,215.62. Following the completion of the sale, the director now owns 10,190 shares of the company’s stock, valued at approximately $1,972,070.70. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Randy Ban sold 12,230 shares of Inspire Medical Systems stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $185.37, for a total value of $2,267,075.10. Following the completion of the sale, the insider now directly owns 3,029 shares of the company’s stock, valued at approximately $561,485.73. The disclosure for this sale can be found here. Insiders sold a total of 16,398 shares of company stock valued at $3,040,961 in the last 90 days. Corporate insiders own 4.50% of the company’s stock.

Inspire Medical Systems Stock Performance

Shares of NYSE:INSP opened at $197.39 on Monday. Inspire Medical Systems, Inc. has a 52-week low of $123.27 and a 52-week high of $330.00. The firm has a market capitalization of $5.98 billion, a P/E ratio of -266.74 and a beta of 1.35. The stock has a 50 day moving average price of $196.89 and a 200-day moving average price of $181.28.

Inspire Medical Systems (NYSE:INSPGet Free Report) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.53. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The company had revenue of $192.51 million during the quarter, compared to analyst estimates of $186.75 million. During the same quarter last year, the company earned $0.10 EPS. The firm’s revenue for the quarter was up 39.6% on a year-over-year basis. On average, equities analysts forecast that Inspire Medical Systems, Inc. will post -0.35 EPS for the current fiscal year.

Inspire Medical Systems Profile

(Free Report)

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

Featured Stories

Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSPFree Report).

Institutional Ownership by Quarter for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.